Use of A New Extracorporeal Membran Oxygenator System and First Experiences

Öz

Objective: In this study, we aimed to share our first experiences about the extracorporeal membrane oxygenator (ECMO) system that we have just started to use and compare it with the system we used before. Methods: Between January 2019 and December 2019, 27 consecutive patients under the age of 18 who were operated for congenital heart disease and needed ECMO support were retrospectively analyzed. İn this period The Medos Deltastream diagonal pump and Sorin Revolution ECMO systems were used. Results: Successful wean was observed in six (42.9%) patients in Medos ECMO group and two (15.4%) in Sorin ECMO group. Five (35.7%) patients discharged in the Medos ECMO group. In Sorin ECMO group all patients died. The difference between the groups in terms of the number of patients discharged was statistically significant (p = 0.02). Lactate clearance was 14 hours in Medos ECMO and 48 hours in Sorin ECMO (p = 0.02). Conclusion: In this study, in which we shared our first experiences regarding the first use of the Sorin ECMO system in the postcardiac pediatric patient group, we observed slower lactate clearance, lower succesful wean and higher mortaly rates. Therefore, this should be taken into account during the use of this system.

Anahtar Kelimeler

• Extracorporeal, oxygenator, mortality, morbidity, Liliput, Hilite, Medos, Revolution

Kaynakça

1. 1. Undar A, Wang S, Arda Ozyuksel A, Rossano JW. Pediatric devices. In: Gregory SD, Stevens MC, Fraser JF. Mechanical Circulatory and Respiratory Support. London: Academic Press. 2017: 271-97.